risk-factors

APPLICANT: MARINA DE GUERRA DEL PERU 
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: No requiere
DIGEMID: Tiene autorización de DIGEMID
Expected Results: a. Design and conceptual framework of industrial application, and its functional approval.
b. Minimum control parameters and sound control of the minimum parameters to guarantee assisted breathing.
c. Programmable logic control of the control variables and
automation and HMI.
d. Electronic interface and development of hydropneumatic valves.
e. Security protocol and alarm system
f. Software implementation and control of the patient's vital parameters.
g. Ventilation system.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Preliminary tests have been carried out
INS: May require positive samples
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results:
It is expected to obtain the validated prototype of a highly sensitive and specific rapid molecular test, based on the RPA isothermal method for the detection of SARS-
COV-2 in human respiratory clinical samples.

APPLICANT: INCA´BIOTEC S.A.C.
SUBJECT:
Development and / or Validation of Detection Systems
STATUS: Declares to have diagnoses of pathologies by LAMP-PCR already developed for animals and humans
INS: Requires samples to DIRESA Tumbes
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results: 1. A fast (~ 30min), accessible (no specialized instrumentation), sensitive and specific (comparable to the RT-qPCR test) molecular diagnostic protocol for the detection of SARS-CoV-2.
2. A diagnostic protocol for the COVID19 virus based on MALDI TOF TOF spectrometric techniques that allow the simultaneous detection and identification of associated pathogens.

APPLICANT: QUALITY PHARMA S.A.C. 
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Without prototype
INS: Request INS support
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results:
Correlation of the proposed detection method with qRT-PCR and / or Qbit and validated electronic equipment.

APPLICANT: UNIVERSIDAD NACIONAL DE TRUJILLO
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Without prototype
INS: 'Does not indicate if INS samples will be required
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results: 1. Have a validated prototype of the development of the RT-LAMP molecular test for the detection of the SARS-CoV-2 virus (COVID-19)
2. The technology package will be presented for transfer.

APPLICANT: PONTIFICIA UNIVERSIDAD CATOLICA DEL PERU
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Metodología similar ya desarrollada a nivel de laboratorio para Dengue y Zika
INS: INS will provide samples
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results: Have a validated "Tiling multiplex PCR" methodology

APPLICANT: INSTITUTO NACIONAL DE SALUD 
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Prototype for RT-LAMP for field detection of TB MDR, Dengue, Zika and Chikungunya
INS: ''Does not indicate if INS samples will be required
DIGEMID: Requires coordination between INS and DIGEMID, being a diagnostic kit
Expected Results: The following: 1) Validated RT-LAMP molecular method, with a sensitivity and specificity of at least 90% (95% CI and precision 5%) that detects the SARS virus visually (colorimetrically) and quickly (from 30 minutes) -CoV 2.
2) Presentation of the transfer and / or implementation of the method to regions.

APPLICANT: UNIVERSIDAD NACIONAL AGRARIA LA MOLINA
SUBJECT:
Development and / or Validation of Detection Systems
STATUS: Without prototype
INS: ''Does not indicate if INS sampleswill be required
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results: It is expected to achieve a highly specific rapid molecular diagnostic kit with short response times (40-60 minutes) that does not require specialized thermocyclists or image detection and analysis equipment.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Development and / or Validation of Detection Systems
STATUS: Without prototype
INS: ''Does not indicate if INS samples will be required
DIGEMID: As it is a diagnostic test, it is considered a medical device, so it will require at the time of authorization
Expected Results: Validated protocol at pilot scale (with samples of synthetic RNA) and functional environment (samples obtained
of COVID-19 patients).

APPLICANT: GREEN BLUE SOLUTIONS SAC
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA: You need to contact MINSA (General Directorate of Epidemiology) to know the data that is being generated and thus the data cube to be generated to perform the machine-learning / deep-learning analysis is more robust and adjusted to the reality of COVID-19
Expected Results: 1) A high-resolution geospatial data cube with a large cuantity of data for the city of Lima.
2) Results of the evaluation of different populations vulnerability within Lima to the severity of the symptoms of COVID-19 using advanced geospatial analysis.
3) It will develop the big data cube framework that could be applied to other regions of Peru, which is necessary before
machine learning / deep learning analysis.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA: 
Contact MINSA (General Directorate of Telehealth) to collect requirements, adjust specifications and work interoperability with current telehealth systems
Expected Results: One (1) digital health tool combination program, containing: a.- one (1) early screening web portal developed as a progressive web app,
which has an application function if used with mobile telephony. b.- one (1) geolocation system (tracker) of the users. c.- the use of telehealth through remote consultation of patients with mild illness and follow-up. It will be able to work together with government health systems

APPLICANT: C.S.T. PERU S.A.C.
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA:
It is a wereable, however, you need coordination with MINSA to:
a.- Cross requirement of important variables to monitor and availability of sensors for those variables; b.- How the KPIs generated are inserted in the current Telehealth models
INS: In case of carrying out clinical tests for validation, the support of INS is required
DIGEMID: Requires DIGEMID evaluation
Expected Results: One (1) scale smartwatch as a functional prototype with the ability to monitor biometric parameters such as temperature, heart beating and location of the patient in isolation at home and at risk population, all data will be stored in the cloud.
One (1) mobile application for displaying individual indicators or global, issuing alerts or notifications for patients, family and / or medical staff. 

APPLICANT: UNIVERSIDAD CATOLICA SAN PABLO
SUBJECT: Tele health and mobile health
STATUS: Without prototype
INS: Does not apply
Expected Results: One (1) mobile application for citizen use that will:
(a) record geographic positions of user movements.
(b) allow to make geolocated detection of events (with GPS position) with many gathered people using photos and videos and voice messages.
(c) allow to see in real time which are the places with crowds.

APPLICANT: PONTIFICIA UNIVERSIDAD CATOLICA DEL PERU
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA: Coordinate with MINSA for access to patient information, treatment, evolution, etc
INS:
Does not apply
Expected Results: a) Patients databas with patients information: treatment and evolution of the hospitalized and non-hospitalized patient, identified by the health entity. b) Web service, which allows the registration of new information related to the patient in the database. c) Statistical analysis for the various profiles of interest:
epidemiology, medical, among others, shown on the web service which can be accessed dynamically and in real time as the data is being stored. d) Publication of results

APPLICANT: UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA:
Coordination with MINSA to raise telemonitoring requirements.
INS: Does not apply
Expected Results: One (1) validated telemonitoring system prototype: Functional service with standardized processes through the application on field work, cultural adaptation and instrument validation.
2) Creation of a technological package for transfer to MINSA (Ministry of Health): Includes documentation for manuals, management guides, instruments and asessing implementation for escalation.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA:
Coordination with MINSA to raise requirements on processes for detection, prevention and treatment
INS: In case of carrying out clinical tests for validation, the support of INS is required
DIGEMID: Requires DIGEMID evaluation
Expected Results: Validated respiratory rate capture system based on comparison with a gold standard (assistance from health personnel). System with adequate level of acceptability by the user (patient and health personnel) and a system that supports remote assistance with patients with possible respiratory problems.

APPLICANT: ASOCIACION PERUANA DE MEDICINA INTENSIVA PEDIATRICA 
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA: Coordination with MINSA to access patient information COVID 19.
INS: Does not apply
DIGEMID: Does not apply
Expected Results: a.- one clinical score: Based on clinical data collected worldwide. This score will allow a prognostic assessment of complications in patients with covid19  infection.
b.- One Web and Android Application for monitoring all patients and identifying those who have high risk criteria for complications. It will have tutorials for the appropriate patient self-evaluation and automated notifications via text message or email of results and tele-consultation in patients with increased risk.
c.- Dispersion map of positive cases for COVID-19 for monitoring each health facility that uses the application.
d.- Real-time identification and care of complications in patients with suspected or confirmed infection by COVID-19 through telemedicine from the application database.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA: Coordination with MINSA - DIRESA Loreto.
INS: Does not apply
DIGEMID: Does not apply
Expected Results: 1) A validated mobile application for health promoters to detect cases and support in containment measures and a Covid-19 reference.
2) Promoters and Indigenous citizen reporters trained in ICTs, leadership strategies, communication and biosecurity to implement digital community surveillance and locally lead an appropriate and timely response to COVID19.
3) Indigenous Communities that have a digital citizenship strategy that articulates epidemiological surveillance, monitoring of Government actions and hospital accompaniment to promote the availability, access, quality and sociocultural relevance of health care against COVID19. 4) Systematization and publication of the implementing experience of the intervention and lessons learned to facilitate its escalation and support the development of a response public policy to pandemics on Amazonian Communities.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA:
Coordination MINSA - DIRESA, access to data, population screening
INS: Does not apply
DIGEMID: Does not apply
Expected Results: 1) Mobile application for monitoring and population screening of COVID-19.
 2) Flows and processes of the application;
3) Documentation and training material for field workers;
4) Training and screening pilot for 2 weeks using the application in a semi-urban setting;
5) Evaluation of the applicability and feasibility of the application;
6) Monitoring and surveillance scheme fed by the app information.

APPLICANT:
SUBJECT:
STATUS:
MINSA:
INS:
DIGEMID:
Expected Results:

APPLICANT: UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS S.A.C.
SUBJECT: Tele health and mobile health
STATUS: With prototype spirometer but not remote monitoring software 
INS: In case of carrying out clinical tests for validation, the support of INS is required
DIGEMID: Requires DIGEMID evaluation
Expected Results: 1 prototype of the digital spirometer device at low cost
1 technology package for transfer and 1 patent and / or utility model application.

APPLICANT: SEGURO INTEGRAL DE SALUD
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA:
Coordinate with MINSA for access to patient information, treatment, evolution, etc
INS: Does not apply
DIGEMID: Does not apply
Expected Results: Fully digital registration system for identification, triage, diagnosis, treatment and follow-up of patients with signs and symptoms of COVID-19 at the carepoint, up to the control board based on international standards of interoperability in health.
Comparative evaluation report of the information systems used by the IPRESS that attended COVID-19patients.

APPLICANT: UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS
SUBJECT: Tele health and mobile health
STATUS: With prototype
MINSA:
Coordinate with MINSA for access to patient information, treatment, evolution, etc
INS: In case of carrying out clinical tests for validation, the support of INS is required
DIGEMID: Analysis required
Expected Results: 1) Possibility of alerting about possible COVID-19 cases from a massive method to cover a greater volume of population, efficiently with less time and cost
2) That the speed of response increases compared to individual tests that can last from 24 hours to days due to high demand
3) Possibility of applying tests or pre-diagnoses without the need for specialized personnel, since the knowledge will be embedded in the machine learning model

APPLICANT: UNIVERSIDAD DE INGENIERIA Y TECNOLOGIA
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA:
Coordinate with MINSA for access to patient information, treatment, evolution, etc
INS: Does not apply
DIGEMID: Does not apply
Expected Results: Prototype of an intelligent web platform to support diagnosis and treatment of patients with COVID19

APPLICANT: SOCIOS EN SALUD SUCURSAL PERU 
SUBJECT: Tele health and mobile health
STATUS: Without prototype
MINSA:
Coordinate with MINSA for access to patient information, treatment, evolution, etc
INS: In case of carrying out clinical tests for validation, the support of INS is required
DIGEMID: Analysis required
Expected Results: It is expected that a COVID-19 score cut-off point alone or associated with other variables can predict early-on the diagnosis of COVID-19 cases who will have a poor clinical course.

APPLICANT: UNIVERSIDAD NACIONAL DE INGENIERIA UNI
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
DIGEMID: DIGEMID opinion required
Expected Results: An optimized process for the functionalization of textiles with ZnO and CuO,
using industrial grade salts (CuSO2 ∙ 5H2O or Zn (NO3) 2.6H2O) that are produced in the country and that can be scalable in any textile company that has the dyeing equipment known as exhaustion and impregnation. This fabric could be used for the manufacture of masks and clothing for health personnel.

APPLICANT: UNIVERSIDAD NACIONAL DE SAN AGUSTIN 
SUBJECT: Technological Developments and Innovation
STATUS: 3D printing prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: Perform the adaptation of an encapsulated video laryngoscope prototype using 3D printing and build the box3 aerosol, once validated proceed to build 50 video laryngoscopes.

APPLICANT: DIGITAL AUTOMATION & CONTROL S.A. 
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: 1. 5 VME equipment implemented.
2. Pre-clinical validation of the 5 equipments.

APPLICANT: CENTRO DE INVESTIGACIONES TECNOLOGICAS, BIOMEDICAS Y MEDIOAMBIENTALES -CITBM
SUBJECT: Technological Developments and Innovation
STATUS: They have a prototype of electrospinning
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: DIGEMID opinion required
Expected Results: Delivery of at least one prototype validated on a pilot scale of a surgical respirator resistant to viral and bacterial contamination based on electrospun membranes, functionalized with nanoparticles, chemical compounds with proven germicidal activity, including among the latter Peruvian phytochemical products with antiviral properties (maca, cat's claw, among others). The functionalized membranes will be used as additional protection barriers in the filters.

by Health Personnel in Vulnerable Zones affected by COVID-19.

APPLICANT:
ASOCIACION CIVIL UNIVERSIDAD DE CIENCIAS Y HUMANIDADES UCH
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: 1 validated prototype at pilot scale .

APPLICANT: LOLIMSA CONSULTORIA DE SISTEMAS S.A.C.
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: DIGEMID opinion required
Expected Results: At the end of the project, final prototypes of the base mask and the 4 filter modules described in Table 1 will be delivered, in addition to a face mask and the external breathing unit. In addition, documentation will be provided: drawings and instructions for manufacturing and procedures for disinfecting the masks to be able to be mass produced in any 3D printer.

APPLICANT: MAXCORP TECHNOLOGIES SOCIEDAD ANONIMA CERRADA 
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: Validated prototype of a portable wireless Vital Signs Monitor (Holter).

APPLICANT: UNIVERSIDAD NACIONAL AGRARIA LA MOLINA
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results:

Validate an ozonization sterilization process in ambulances and isolation gurneys used in the transfer of patients infected with SARS-CoV-2.

Establish a detailed procedure of the stages of sterilization by Ozonation to be used by health personnel who transfer suspicious patients and confirmed cases with COVID-19.



APPLICANT: PONTIFICIA UNIVERSIDAD CATOLICA DEL PERU
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: A pulmonary ventilator prototype applicable to patients requiring COVID-19 intensive respiratory therapy.

APPLICANT: ASOCIACION LIDERANDO
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results:
To have developed 50 portable self-control and telemonitoring equipment that have contributed to the promotion, prevention and protocol of health treatment of at least 400 patients with symptoms of COVID-19 and other ailments.
• The virtual doctor´s office will obtain a database with valuable information for
promote, prevent and treat public health via telehealth.
• The technical experience gained will allow starting new lines of research -
technological development in the field of telemedicine and telehealth in our country.
• From this development you can propose the innovation of a product
(digital vital signs meter) and the implementation of consulting services in the field of medical technology.

APPLICANT: PONTIFICIA UNIVERSIDAD CATOLICA DEL PERU
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: 2 digital CAD prototypes of the two equipments considered in the proposal (the first one for preliminary tests, and the final one with the corresponding adjustments after the tests).
2 physical prototypes manufactured from the two equipments considered in the proposal (the first one with the initial adaptations and the final one with the adjustments after the tests).

APPLICANT: UNIVERSIDAD TECNOLOGICA DEL PERU S.A.C. O UTP S.A.C.
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Se requiere coordinar con DIGEMID 
Expected Results: As a result of the project, it is expected to have a low-cost remote physiological parameter measurement kit adaptable to cell phones. 

APPLICANT: WAKA-S TEXTILES FINOS S.A.C.
SUBJECT: Technological Developments and Innovation
STATUS: Sin prototipo
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Verificar si requiere DIGEMID
Expected Results: At the end of the investigation we must be able to offer to the market a
reusable alternative, easy to produce and similar to the N95 mask at a
competitive price.

in Región La Libertad-Perú

APPLICANT:
UNIVERSIDAD PRIVADA ANTENOR ORREGO
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: a) A functional prototype that integrates a mobile isolation capsule and a
automatic assisted breathing device Interconnected to IOT.
b) A Technology Package for transfer and / or implementation.

APPLICANT: UNIVERSIDAD NACIONAL TECNOLOGICA DE LIMA SUR - UNTELS
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Consultar a DIGEMID si este dispositivo requiere su autorización
Expected Results: 01 validated and functional prototype of assistance robot.

APPLICANT: UNMSM-UNI
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: Have two models of mechanical respirators that have a favorable technical opinion from the Medical College of Peru, Intensivists chapter.

APPLICANT: VENTURE S.A.C. 
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: The proposed equipment has been successfully implemented 4 times. In 2004 the artificial respirator came into operation with a patient with amyotrophic lateral sclerosis for six months, later two artificial respirators were developed for pediatric patients with respiratory problems in the Intensive Care Unit of the Cayetano Heredia Hospital, monitored by Dr. Daniel Porturas , Head of the Pediatric ICU.

APPLICANT: Universidad Nacional de Piura
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: Biomedical validation of a functional prototype.
Present the Technology Package for its transfer and / or implementation

APPLICANT: UTEC
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: 1 prototype validated in animal model.

APPLICANT: UPCH
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: In case of carrying out clinical tests for validation, the support of INS is required.
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: A prototype that can be scaled for national production level.

APPLICANT: UNMSM
SUBJECT: Technological Developments and Innovation
Expected Results: Recovery of approximately 20% of mechanical and related ventilation equipment.

APPLICANT: RUWAC SAC
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: 5 prototypes, at the end of the project there will be a medical device, portable, easy to use, administered rapidly and massively in patients with respiratory disturbances caused by Covid-19 in order to improve their oxygenation and increase their life expectancy. - This device is expected to be used in hospitals, clinics and health facilities from the Level I-1. Also that it can be used in homes and in places where the external oxygen disposal such as remote communities throughout Peru and places where have supplemental oxygen from external sources such as oxygen balloons. - The device is expected to be portable, user-friendly and can be easily and safely transported to difference from oxygen balloons

APPLICANT: NEXO EQUIPAMIENTO Y SERVICIOS S.A.C.
SUBJECT: Technological Developments and Innovation
STATUS: With prototype
INS: Without information
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: A portable device that combines sterilization techniques, UV-C ultraviolet light, ozone and 99.9% particle retention with HEPA filters to achieve inactivation of COVI-19 in closed environments.

APPLICANT: UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS S.A.C. 
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: Without information
DIGEMID: Because it is a high-risk medical device, authorization from DIGEMID is required
Expected Results: No clear results in this proposal

APPLICANT: UNIVERSIDAD NACIONAL JOSE FAUSTINO SANCHEZ CARRI
SUBJECT: Technological Developments and Innovation
STATUS: Without prototype
INS: Without information
DIGEMID: Without information
Expected Results: Prototype of a booth at the entrance of premises, within which people move (medical personnel, police personnel and patients), who may or may not carry the virus. Inside the house, people are exposed to two curtains of ultraviolet light of type C and to another curtain of air at a moderate temperature.

APPLICANT: UNIVERSIDAD CATOLICA DE SANTA MARIA
SUBJECT: Treatment
STATUS: Without prototype
INS: Does not apply
Expected Results: Obtain plant extracts that interfere with the binding and entry of the SARS-CoV-2 virus into the primary cells affected by pulmonary epithelium in an in vitro model, evaluating their efficacy in reducing the replication and viral load.
Subsequently, these extracts will allow the start of clinical trial studies in animal and human models, and if it demonstrates effectiveness, it will be able to contribute to the international community, with a new therapeutic option.

APPLICANT: INSTITUTO NACIONAL DE SALUD 
SUBJECT: Treatment
STATUS: The prototype multi-epitope vaccine for Carrion's disease has been designed with optimal results.
INS: Clinical trials are required for validation, INS support is required 
DIGEMID: Requires the purchase of research supplies
MINSA:
Does not apply
Expected Results: Demonstrate the effectiveness of antibodies (generated by immunization with the vaccine prototype) in neutralizing the virus in in vitro tests.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Treatment
STATUS: Without prototype
INS: Clinical trials are required for validation, INS support is required 
DIGEMID: Requires the purchase of research supplies
MINSA:
Does not apply
Expected Results: The results obtained will allow: (a) to generate sufficient data to propose new clinical trials if there are already molecules on the market; (b) if there are new molecules, propose l & D & i programs for new pharmaceuticals against COVID-19. In both cases, the objective is to propose a pharmacological therapy to combat COVID-19.

APPLICANT: UNIVERSIDAD CATOLICA DE SANTA MARIA 
SUBJECT: Treatment
STATUS: Without prototype
INS: Clinical trials are required for validation, INS support is required 
DIGEMID: DIGEMID approval required
Expected Results: Validated prototype at medium scale for the production of CQ and HCQ.
• CQ and HCQ production on a small and medium scale.
• Design of a pilot model for CQ and HCQ production

APPLICANT: UNIVERSIDAD NACIONAL DEL CENTRO DEL PERU
SUBJECT: Treatment
STATUS: Without prototype
INS: Does not apply
DIGEMID: Requires the purchase of research supplies
Expected Results: Decide the antiviral activity of benzyl isothiocyanate from Tropaeolum majus as an alternative treatment for coronavirus conditions.

APPLICANT: FARMACOLOGICOS VETERINARIOS S.A.C.
SUBJECT: Treatment
STATUS: Without finished prototype
INS: Clinical trials are required for validation, INS support is required 
DIGEMID: Requires the purchase of research supplies
Expected Results: At the end of the study we hope to demonstrate that the vaccine developed will not present adverse effects in mice, monkeys or humans. Additionally, having evaluated all the immunogenic parameters, both at the level of antibodies and cells using flow cytometry, we hope that the serum of these immunized animals and humans have the ability to neutralize the virus in an in-vitro assay.

APPLICANT: INSTITUTO ANDINO DE SISTEMAS
SUBJECT: Epidemiological and Social Studies
STATUS: Without Prototype
INS: Does not apply
DIGEMID: Does not apply
MINSA:
Does not apply
Expected Results: Collection and validation of information, as well as expert validation of the causal model and the criteria that support it. Model validation and taken into consideration for integration as part of government decision-making tools.

APPLICANT: UNIVERSIDAD DE INGENIERIA Y TECNOLOGIA
SUBJECT: Epidemiological and Social Studies
STATUS: Without Prototype
INS: Does not apply
DIGEMID: Does not apply
MINSA:
Does not apply
Expected Results: With the present project, it's expected to increase the capacity of COMCIENCIA to create more scientific material contrasted with published scientific articles and thus, increase its presence in communication networks to reach more people in Peru and increase the levels of scientific information they have access to. In addition, it is intended to collect more data to share the experience in a publication in scientific journals.

APPLICANT: UNIVERSIDAD RICARDO PALMA 
SUBJECT: Epidemiological and Social Studies 
STATUS: Without Prototype
INS: Requires coordinating samples with INS / hospitals
Expected Results: As a result, it is expected to know the prevalence of SARS CoV-2 coinfection with other respiratory pathogens and its implications in terms of mortality and complications.

APPLICANT: UNIVERSIDAD PERUANA CAYETANO HEREDIA
SUBJECT: Epidemiological and Social Studies
STATUS: With Prototype
INS: Requires coordinating samples with INS
DIGEMID: If you require importation of products for research without sanitary registration, you need to coordinate with DIGEMID
Expected Results: 1) Integrated, scalable and decentralized sequencing and analysis system for viral genomes.
2) Obtaining 500-1,000 sequenced genomes in the first 6 months of the study. Models of transmission, evolution and population dynamics of the virus will be formulated.
3) Genomic surveillance pilot in two regional laboratories, with the possibility of expansion to additional regions in a second phase of the project. Implementation and training in these laboratories, in coordination with INS and local universities.

APPLICANT: PONTIFICIA UNIVERSIDAD CATOLICA DEL PERU
SUBJECT: Epidemiological and Social Studies
STATUS: Without Prototype
INS: Si requiere muestras necesita coordinar con INS
DIGEMID: Si requiere de importación de productos para investigación sin registro sanitario necesita coordinar con DIGEMID
MINSA:
Para el desarrollo de politicas publicas se deberá trabajar con MINSA
Expected Results: Information will be obtained on the environmental deposition for SARS-CoV2 in the patient's home: surfaces and air transmission, as well as the characteristics of the home and practices that may impact it. These results may better guide the recommendations for patients in isolation at home and may be extended to public places. Additionally, information on secondary intra-household infections and asymptomatic cases that are identified will be obtained. Consequently, the findings of this study will be transmitted in public policy proposals to the health authorities. These results will be reported in an article in a peer-reviewed indexed journal. An event will also be held to disseminate results through digital media, as the situation allows.

APPLICANT: UNIVERSIDAD DEL PACIFICO
SUBJECT: Epidemiological and Social Studies 
STATUS: With Prototype
INS: Does not apply
DIGEMID: Does not apply
MINSA:
Para datos epidemiologicos este proyecto deberá coordinar con CDC del MINSA
Expected Results: 1. An algorithm that allows detecting infected before they develop symptoms early.
2. Suggesting users of the PERU'ENTUSMANOS application actions based on calculations.
3. A reporting system of the infected for decision makers (PCM, MINSA, etc.)

APPLICANT: MINISTERIO DE SALUD 
STATUS: Epidemiological and Social Studies 
INS: They have previous results on all four criteria.
DIGEMID: Does not apply
Expected Results: Prevalence and risk factors of anxiety disorder
- Prevalence and risk factors for depression disorder
- Prevalence and risk factors of panic disorder
- Prevalence and risk factors of post traumatic stress.

APPLICANT: INSTITUTO NACIONAL DE SALUD
SUBJECT: Epidemiological and Social Studies
STATUS: To date there are two genomes sequenced by our Laboratory. Furthermore, more genomes are in the process of sequencing. 
INS: Does not apply
DIGEMID: Si requiere de importación de productos para investigación sin registro sanitario necesita coordinar con DIGEMID
Expected Results: (i) Have a map of the national distribution of SARS-COV2 genotypes.
(ii) Establish phylogenetic relationships between viruses in different regions of the country
(iii) Having established a protocol for the determination of the viral load in samples of nasopharyngeal swab.

Back To Top